The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of serious complications.
Read more at NBC News
The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of serious complications.
Read more at NBC News